Organisation paid for research Program year 2025 Source: CMS Open Payments

C Marc LLC

Neither a doctor nor a teaching hospital

Research payments

$126,216

8 payments

Through program year 2025, C Marc LLC is reported as receiving $126,216 in research payments, across 8 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $95,818 1
2020 Research $16,163 2
2019 Research $14,235 5

Breakdown

Who paid Research payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $114,743 5 payments
  2. AstraZeneca UK Limited $8,606 2 payments
  3. Amgen Inc. $2,868 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. A Phase III, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Effect of AZD0780 on Low-Density Lipoprotein Cholesterol in Patients With Heterozygous Familial Hypercholesterolaemia $95,818 1 payment
  2. A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia $27,530 6 payments
  3. Phase 3 Pediatric FH $2,868 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record